Quantcast
Last updated on April 19, 2014 at 18:42 EDT

Latest Laboratories Stories

Color-tunable Photonic Fibers Mimic The Fruit Of The “Bastard Hogberry” Plant
2013-01-28 14:29:04

Harvard School of Engineering and Applied Sciences A team of materials scientists at Harvard University and the University of Exeter, UK, have invented a new fiber that changes color when stretched. Inspired by nature, the researchers identified and replicated the unique structural elements that create the bright iridescent blue color of a tropical plant´s fruit. The multilayered fiber, described today in the journal Advanced Materials, could lend itself to the creation of smart...

2013-01-22 08:30:36

SAN DIEGO, Jan. 22, 2013 /PRNewswire/ -- INOVA Diagnostics is pleased to announce the full commercial launch of BIO-FLASH, a rapid-response chemiluminescent analyzer for use by clinical reference and hospital laboratories. This signals the global release of BIO-FLASH along with QUANTA Flash® reagents for autoimmune disease diagnostic testing. BIO-FLASH is a technologically advanced analyzer which offers full automation of a broad menu of highly accurate QUANTA Flash immunoassays for...

2013-01-10 05:01:24

Leading National Reference Laboratory Services Provider, ARUP Laboratories, Introduces Blood Test to Aid in the Early Detection of Lung Cancer. Innovative Blood Test will assist Clinicians in Identifying Deadly Disease Earlier Salt Lake City, UT (PRWEB) January 09, 2013 ARUP Laboratories announced today that it is entering into an agreement with Kansas-based Oncimmune® USA LLC to offer EarlyCDT®-Lung, the blood test that aids in the risk assessment and the early detection of lung...

2013-01-08 16:23:43

PORTSMOUTH, N.H., Jan. 8, 2013 /PRNewswire-iReach/ -- Harbor Consulting IP Services, Inc. ("HCIP") proudly announces that the company has established the Harbor Consulting IP Services, Inc. Charitable Fund ("the Fund") at the Dana-Farber Cancer Institute ("DFCI") in support of DFCI's ongoing cancer research, treatment, and patient care. Following HCIP's involvement with DFCI's Gene Display Wall and Vitals Bay sponsorship programs, creating the Fund extends HCIP's longstanding commitment to...

2013-01-02 08:23:40

MADISON, N.J. and WORCESTER, Mass., Jan. 2, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has completed its previously announced acquisition of the Worcester-based clinical outreach laboratory business of UMass Memorial Medical Center, a member of UMass Memorial Health Care, the largest health care system in Central New England. Separately, the company also announced today that it has acquired UMass...

2012-12-17 12:21:40

BOSTON, Dec. 17, 2012 /PRNewswire/ -- The Fraunhofer Center for Sustainable Energy Systems (CSE) has been selected to receive project funding from the U.S. Department of Energy's (DOE) SunShot Initiative, a collaborative national effort to make solar energy cost-competitive with other forms of energy by the end of the decade. CSE's 5-year, $11.7M research project focuses on the development of "plug and play" solar photovoltaic (PV) systems that can be purchased, installed, and connected by...

2012-12-11 12:27:53

Proof-of-concept animal study selected as one of the best presentations at 54(th) American Society of Hematology Annual Meeting and Exposition BOSTON, Dec. 11, 2012 /PRNewswire-USNewswire/ -- Researchers at Dana-Farber/Children's Hospital Cancer Center (DF/CHCC) have taken the first preliminary steps toward developing a form of gene therapy for sickle cell disease. In an abstract presented on Dec. 10 at the 54(th) annual meeting of the American Society of Hematology, the research...

2012-12-11 12:00:01

Young patients with an aggressive form of leukemia who are likely to relapse after chemotherapy treatment can significantly reduce those odds by receiving additional courses of chemotherapy, suggest the findings of a clinical trial led by investigators at Dana-Farber/Children's Hospital Cancer Center in Boston. The trial leaders will present the results of the Dana-Farber Cancer Institute ALL Consortium study, which involved nearly 500 patients under age 18 with B-precursor acute...

2012-12-04 12:25:39

MADISON, N.J., Dec. 4, 2012 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that the specimen biorepository of its Quest Diagnostics Clinical Trials business, a leader in laboratory testing services to advance drug discovery and development, has been accredited by the College of American Pathologists (CAP), the international laboratory accrediting organization. Based at the Quest Diagnostics clinical...

2012-11-16 12:26:02

BETHLEHEM, Pa., Nov. 16, 2012 /PRNewswire/ -- Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized medicine for new and existing therapeutics, announced today that Mark D. Myslinski has been appointed senior vice president and chief commercial officer of the company. Mr. Myslinski has nearly 30 years of life sciences and diagnostics industry experience with Fortune 100 and venture-backed startup...